HMGCS1 and acute myeloid leukemia: Further study of the expression level of HMGCS1 and metabolic intermediates of cholesterol synthesis with more chemoresistant AML cell lines will help reveal whether HMGCS1 increases cell growth and reduces drug sensitivity through subsequent activation of the MAPK pathway.